Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol Fumarate in Asthma
NCT00215358Phase 2Completed
- Sponsor
- Dey
- Start
- Jul 2002
- Primary completion
- Oct 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of formoterol in asthma (2 arms), sponsored by Dey. Primary endpoint: Measure of lung function. Started Jul 2002; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00215358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215358.